Trading Report: The AGF Investments Inc. Reached $4,386,000 position of Amsurg Corp. (AMSG)

The AGF Investments Inc. Reached $4,386,000 position  of Amsurg Corp. (AMSG)

AGF Investments Inc. lowered its stake in Amsurg Corp. (NASDAQ:AMSG) by 6.4% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 56,589 shares of the company’s stock after selling 3,870 shares during the period. AGF Investments Inc.’s holdings in Amsurg Corp. were worth $4,386,000 at the end of the most recent reporting period.

Other large investors also recently modified their holdings of the company. Aperio Group LLC increased its position in Amsurg Corp. by 9.7% in the first quarter. Aperio Group LLC now owns 7,951 shares of the company’s stock worth $593,000 after buying an additional 705 shares during the period. Teachers Advisors Inc. increased its position in Amsurg Corp. by 5.9% in the first quarter. Teachers Advisors Inc. now owns 90,754 shares of the company’s stock worth $6,770,000 after buying an additional 5,036 shares during the period. BlackRock Inc. increased its position in Amsurg Corp. by 13.7% in the first quarter. BlackRock Inc. now owns 21,588 shares of the company’s stock worth $1,610,000 after buying an additional 2,593 shares during the period. BlackRock Group LTD increased its position in Amsurg Corp. by 24.4% in the first quarter. BlackRock Group LTD now owns 38,307 shares of the company’s stock worth $2,858,000 after buying an additional 7,509 shares during the period. Finally, M&T Bank Corp increased its position in Amsurg Corp. by 39.8% in the first quarter. M&T Bank Corp now owns 5,538 shares of the company’s stock worth $413,000 after buying an additional 1,576 shares during the period. 98.45% of the stock is owned by institutional investors.

Amsurg Corp. (NASDAQ:AMSG) traded down 0.55% during mid-day trading on Friday, hitting $58.16. 2,521,917 shares of the stock were exchanged. Amsurg Corp. has a 52 week low of $57.75 and a 52 week high of $87.29. The stock’s 50-day moving average is $65.23 and its 200 day moving average is $72.25. The company has a market capitalization of $3.13 billion, a PE ratio of 17.26 and a beta of 0.68.

Amsurg Corp. (NASDAQ:AMSG) last announced its quarterly earnings results on Tuesday, August 2nd. The company reported $1.10 EPS for the quarter, beating the Zacks’ consensus estimate of $1.08 by $0.02. The business earned $758.50 million during the quarter, compared to analyst estimates of $769.88 million. Amsurg Corp. had a net margin of 6.53% and a return on equity of 8.20%. Amsurg Corp.’s quarterly revenue was up 21.5% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.97 EPS. On average, analysts anticipate that Amsurg Corp. will post $4.33 EPS for the current year.

AMSG has been the subject of a number of analyst reports. Jefferies Group reaffirmed a “buy” rating on shares of Amsurg Corp. in a research report on Sunday, July 3rd. Zacks Investment Research raised shares of Amsurg Corp. from a “hold” rating to a “buy” rating and set a $88.00 target price for the company in a research report on Monday, July 11th. Cantor Fitzgerald reaffirmed a “buy” rating and issued a $95.00 target price on shares of Amsurg Corp. in a research report on Thursday, July 14th. Citigroup Inc. initiated coverage on shares of Amsurg Corp. in a research report on Monday, September 26th. They issued a “buy” rating and a $79.00 target price for the company. Finally, KeyCorp reaffirmed a “positive” rating and issued a $87.00 target price on shares of Amsurg Corp. in a research report on Tuesday, October 4th. Three research analysts have rated the stock with a hold rating and ten have issued a buy rating to the company’s stock. The company presently has an average rating of “Buy” and an average price target of $92.09.

In other news, insider Robert Jon Coward sold 7,500 shares of the company’s stock in a transaction on Friday, August 26th. The shares were sold at an average price of $63.65, for a total value of $477,375.00. Following the completion of the sale, the insider now owns 97,507 shares in the company, valued at approximately $6,206,320.55. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 2.30% of the stock is currently owned by insiders.

About Amsurg Corp.

AmSurg Corp. is a surgical center and physician services company. The Company is an owner and operator of ambulatory surgery centers (ASCs) in the United States. The Company is also a provider of outsourced physician services in the areas of anesthesiology, children’s services, emergency medicine and radiology.

Related posts

Leave a Comment